The acquisition is expected to be accretive to Chart’s 2011 earnings, excluding restructuring costs, and if future contingent payments are earned, the accretion to Chart’s earnings would be expected to increase.
The other financial terms of the all-cash transaction were not disclosed.
Chart BioMedical president Steve Shaw said that the acquisition has been completed, they look forward to integrating SeQual and its leading portable, non-delivery oxygen concentrator during 2011.
CAIRE is a provider of respiratory care products for the home health care market, manufactures a full line of liquid oxygen reservoirs and liquid oxygen portables sold under the Liberator, Companion, Spirit and HELiOS brands.
